Evidence map›Paper›PMID 42738967›Full record

SynthesisNutrients2026

Efficacy and Safety of

Franco Rodríguez-Brown, Jamee Guerra Valencia, Akram Hernández-Vásquez

Abstract readSystematic ReviewMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Franco Rodríguez-BrownSegunda Especialidad en Nutrición Pediátrica, Universidad Científica del Sur, Lima 15067, Peru.
Jamee Guerra ValenciaFacultad de Ciencias de la Salud, Universidad Privada del Norte, Lima 15314, Peru.
Akram Hernández-VásquezEpidemiology and Health Economics Research (EHER), Universidad Científica del Sur, Lima 15067, Peru.ORCID 0000-0003-1431-2526

Funding

Universidad Científica del Sur
6 · The paper itself

Abstract

BACKGROUND/

objective

methodsThis review was registered in PROSPERO (CRD42024618099). PubMed, Cochrane Library, Embase, Web of Science, Scopus, CINAHL, and LILACS were searched from inception to 8 April 2026, for randomized controlled trials (RCTs) enrolling children ≤ 18 years with Rome III/IV-defined FAPDs receiving

resultsSeven RCTs (513 participants) were included. Pain severity showed no significant difference at end of follow-up (SMD -0.58; 95% CI -1.32 to 0.16; I

conclusionsCurrent evidence does not support a consistent beneficial effect of

Indexed as

Abdominal PainLimosilactobacillus reuteriProbioticsAdolescentChildHumansQuality of LifeRandomized Controlled Trials as TopicTreatment Outcomeabdominal painadolescentchildhumansLimosilactobacillus reuterimeta-analysispain measurementquality of liferandomized controlled trialssystematic review

Identifiers

PMID42738967
PMCPMC13567511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.